Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 15
- −2 vs. Q4 2022
- Portfolio value
- $39.6M
- +$441.1K (+1.1%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LANWFLanvin Group Holdings Ltd | *W EXP 99/99/999 | 12,000 | $4.50K | <0.1% | 00.0% | Unchanged | History |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 39,773 | $6.97K | <0.1% | 00.0% | Unchanged | – |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 21,333 | $40.5K | 0.1% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 68,324 | $129.8K | 0.3% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 40,581 | $335.6K | 0.8% | −44,147−52.1% | Reduced | History |
| ALLKAllakos Inc. | COM | 86,533 | $385.1K | 1.0% | +68,262+373.6% | Added | History |
| CMPXCompass Therapeutics, Inc. | COM | 211,740 | $675.5K | 1.7% | +581+0.3% | Added | History |
| MTEMMolecular Templates, Inc. | COM | 2,052,991 | $779.9K | 2.0% | 00.0% | Unchanged | History |
| Alps ETF Tr00162Q452 | ALERIAN MLP | 29,500 | $1.14M | 2.9% | 00.0% | Unchanged | – |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 156,651 | $1.35M | 3.4% | +429+0.3% | Added | – |
| SPDR Series Trust78468R556 | SP O&G EXPL PRO | 17,500 | $2.23M | 5.6% | 00.0% | Unchanged | – |
| RZLTRezolute, Inc. | COM NEW | 1,403,157 | $2.69M | 6.8% | 00.0% | Unchanged | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 15,947 | $6.53M | 16.5% | 00.0% | Unchanged | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 6,039,028 | $9.84M | 24.9% | 00.0% | Unchanged | History |
| SVRASavara Inc | COM | 6,896,551 | $13.4M | 34.0% | 00.0% | Unchanged | History |
Sold out since Q4 2022 (2)
Positions held at the end of Q4 2022 that are gone from this filing.